Coltene Holding AG operates within the Dental equipment and supplies sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Coltene Holding AG with three other
medical equipment manufacturers in Europe:
Stratec Biomedical AG
sales of 144.86 million Euro [US$161.85 million]
of which 104%
Consort Medical Plc
of the United Kingdom
(£100.01 million [US$151.30 million]
based in the United Kingdom
(£101.72 million [US$153.89 million]
of which 100%
was Retinal Equipment).
During the year ended December of 2014, sales at
Coltene Holding AG were 162.35 million Swiss Francs (US$166.85 million).
a very small
increase of 1.5%
versus 2013, when the company's sales were 160.01 million Swiss Francs.
This was the third consecutive year of growth at Coltene Holding AG.
The sales level in 2014 was fairly close to the level five years ago: in 2009, Coltene Holding AG had sales
of 151.39 million Swiss Francs.
Sales of Treatment Auxiliaries saw an increase
that was more than double the company's growth rate: sales were up
25.1% in 2014, from
17.00 million Swiss Francs to 21.27 million Swiss Francs.
Coltene Holding AG also saw significant increases in sales in
Prosthetics (up 6.9% to 35.45 million Swiss Francs)
Rotary (up 14.1% to 12.44 million Swiss Francs)
Not all segments of Coltene Holding AG experienced an increase in sales in 2014:
sales of Other and Consolidation fell 36.2% to 2.89 million Swiss Francs.
(However, this segment's sales were only a very small portion of the company's overall sales).
Coltene Holding AG also experienced decreases in sales in
Restoration (down 6.8% to 41.82 million Swiss Francs)
Infection Control (down 13.1% to 10.42 million Swiss Francs)